GLP-1 Drug Interactions: The Complete 2026 Medication Compatibility Guide

GLP-1 receptor agonists interact with other medications in ways that every patient and prescriber should understand. Some interactions are clinically significant and require dose adjustments. Others are theoretical concerns that sound alarming but rarely cause problems in practice. This guide separates the two with evidence-based clarity.

How GLP-1 Medications Affect Drug Absorption

The most important pharmacological concept to understand is that GLP-1 agonists slow gastric emptying. This is one of the mechanisms through which they reduce appetite, but it also means that orally administered medications may be absorbed more slowly, which can alter their peak blood levels and timing of effect.

For most medications, this slowed absorption doesn't change the total amount of drug absorbed — just when it reaches peak concentration. However, for medications where timing is critical (certain antibiotics, oral contraceptives, narrow therapeutic index drugs), this delay can be clinically meaningful.

High-Priority Interactions: Dose Adjustments Likely Needed

Insulin and Sulfonylureas

This is the most clinically significant interaction category. GLP-1 medications lower blood glucose independently, and combining them with insulin or sulfonylureas (glipizide, glyburide, glimepiride) creates a compounding hypoglycemic effect. Most endocrinologists reduce insulin doses by 20-30% when initiating a GLP-1 agonist in a type 2 diabetes patient and further adjust based on glucose monitoring. Sulfonylurea doses may also need reduction or discontinuation.

Oral Contraceptives

Delayed gastric emptying can reduce the absorption of oral contraceptive pills. While clinical studies haven't shown a definitive increase in contraceptive failure rates, the theoretical concern is real enough that the FDA labeling for semaglutide recommends patients using oral contraceptives either switch to a non-oral method (IUD, patch, ring, injection) or use backup contraception for 4 weeks after each dose increase during GLP-1 titration.

Warfarin (Coumadin)

Warfarin has a narrow therapeutic index, meaning small changes in absorption can shift INR (International Normalized Ratio) values into dangerous ranges. Patients on warfarin who start a GLP-1 agonist should have more frequent INR monitoring — weekly for the first 4-6 weeks, then at each dose increase. Dose adjustments may be necessary.

Levothyroxine (Thyroid Medication)

Levothyroxine absorption is particularly sensitive to timing and stomach conditions. GLP-1-induced delayed gastric emptying can reduce peak absorption. The clinical recommendation: take levothyroxine at least 30-60 minutes before your first meal on an empty stomach (which many patients already do), and have your TSH levels monitored 6-8 weeks after starting a GLP-1 and after each significant dose change.

Moderate Interactions: Monitor but Usually Manageable

Metformin

GLP-1 agonists and metformin are frequently prescribed together, and this combination is generally well-tolerated. Both medications can cause GI side effects (nausea, diarrhea), so the combined GI burden can be greater than either alone. If GI symptoms are problematic, the extended-release formulation of metformin is better tolerated. No dose adjustment of metformin is typically needed.

ACE Inhibitors and ARBs (Blood Pressure Medications)

GLP-1 medications can modestly reduce blood pressure independently. Patients on antihypertensive medications may experience a greater blood pressure reduction than expected, particularly during the first few months. Monitor blood pressure regularly and be alert for symptoms of hypotension (dizziness, lightheadedness on standing). Your provider may need to reduce your blood pressure medication doses as weight loss progresses.

NSAIDs (Ibuprofen, Naproxen)

Both GLP-1 medications and NSAIDs can affect kidney function. The combination isn't contraindicated, but patients should stay well-hydrated and avoid prolonged NSAID use, particularly at higher GLP-1 doses. If you need regular pain management, discuss alternatives like acetaminophen with your provider.

Psychiatric Medications (SSRIs, SNRIs, Antipsychotics)

This is an area of active research. Some psychiatric medications (particularly olanzapine, quetiapine, and mirtazapine) promote weight gain, which may partially counteract GLP-1 efficacy. This doesn't mean you should stop psychiatric medications to start a GLP-1 — mental health treatment takes clinical priority. But it's a factor your provider should consider when setting realistic weight loss expectations. Conversely, some patients find that GLP-1-related weight loss improves their depression and anxiety symptoms, though this should never replace psychiatric care.

Low-Concern Interactions: Theoretical but Rarely Problematic

Statins (Atorvastatin, Rosuvastatin)

No clinically significant interaction. Statins and GLP-1 agonists can be used together safely, and in fact, many patients on GLP-1 medications see improved lipid profiles that may reduce their statin requirements over time.

Proton Pump Inhibitors (Omeprazole, Pantoprazole)

PPIs alter stomach pH, and GLP-1 medications slow gastric emptying, but these effects don't meaningfully interfere with each other. Both can be used concurrently. Some clinicians actually prescribe short courses of PPIs to help manage GLP-1-related acid reflux during titration.

Supplements and Vitamins

Fat-soluble vitamins (A, D, E, K) and supplements may be absorbed somewhat more slowly with GLP-1 medications, but total absorption is unlikely to be significantly affected for most patients. If you're taking supplements, maintain consistent timing relative to meals.

The Medication Review Every GLP-1 Patient Needs

Before starting GLP-1 treatment, every patient should do a comprehensive medication reconciliation with their prescriber. This means listing every prescription medication, over-the-counter drug, and supplement you take. Your provider should review each one for potential interactions and establish a monitoring plan.